Skip to main content

View Resource

Published

Long-term impact of SARS-CoV-2 on recurrent COPD exacerbations.
Henry SS. eBioMedicine 2026;:https://doi.org/10.1016/j.ebiom.2026.106212.
[SARS-CoV-2 infection could increase the long-term risk of recurrent chronic obstructive pulmonary disease (COPD) exacerbations. This study investigated the long-term risk of COPD exacerbations following SARS-CoV-2 infection, with comparisons by hospitalisation status. COVID-19 hospitalisation was associated with a sustained increased risk of recurrent COPD exacerbations, underscoring the need for long-term pulmonary follow-up and targeted interventions in this high-risk population.]
Freely available online
Age Groups
Adults
Older People
Conditions and Lifestyle Factors
Chronic Obstructive Pulmonary Disease
Coronavirus Infections
Settings
Hospital Ward
Intensive Care
Staff Groups
Medic